Tofajak Tablet

Medicine Overview

Tofajak Tablet is a targeted medication containing tofacitinib, used to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. By inhibiting Janus kinase (JAK) enzymes, Tofajak Tablet reduces inflammation and immune system overactivity, relieving joint pain, swelling, and stiffness. Ideal for adults with moderate to severe autoimmune diseases, it helps improve mobility and quality of life. Tofajak Tablet supports long-term disease management by controlling symptoms and preventing joint damage. Trusted for its efficacy and safety, it is a valuable option for patients seeking advanced treatment for chronic inflammatory disorders.